New eye drops aim to halt Vision-Threatening cornea disease
NCT ID NCT07388069
Summary
This study is testing a new eye drop called TN-001 to see if it is safe and can stop the progression of keratoconus, a disease that thins and warps the clear front part of the eye (cornea). About 20 adults with worsening keratoconus will use the drops twice daily for 3-6 weeks while doctors monitor their eyes closely. The main goal is to see if the drops are well-tolerated and if they can strengthen the cornea to prevent further damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ophthalmic Trials Australia
Brisbane, Queensland, 4005, Australia
Conditions
Explore the condition pages connected to this study.